Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
Investing

21 Hong Kong-listed firms in Forbes’ inaugural list of top Asian corporates, but share prices tell a different story

  • Forbes’ inaugural ‘Best Over a Billion’ list comprises Asia’s top 200 companies with revenues of over US$1 billion
  • Average share price loss for the 21 Hong Kong companies in the list was 12.68 per cent against the Hang Seng Index decline of 7.17 per cent

Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
READ FULL ARTICLE